Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Authors
Keywords
-
Journal
PLoS One
Volume 11, Issue 3, Pages e0151565
Publisher
Public Library of Science (PLoS)
Online
2016-04-01
DOI
10.1371/journal.pone.0151565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
- (2015) Paul Sondo et al. MALARIA JOURNAL
- Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine
- (2014) Meera Venkatesan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- In VivoSelection of Plasmodium falciparumPfcrtandPfmdr1Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso
- (2014) Vito Baraka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
- (2014) Halidou Tinto et al. MALARIA JOURNAL
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of artesunate-amodiaquinevs. artemether-lumefantrine for the treatment of uncomplicatedfalciparummalaria in Nanoro, Burkina Faso: a non-inferiority randomised trial
- (2014) Halidou Tinto et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Profile: Nanoro Health and Demographic Surveillance System
- (2012) K. Derra et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
- (2012) Aung Pyae Phyo et al. LANCET
- Three years of insecticide resistance monitoring in Anopheles gambiae in Burkina Faso: resistance on the rise?
- (2012) Athanase Badolo et al. MALARIA JOURNAL
- Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
- (2011) Steffen Borrmann et al. PLoS One
- Association Between the pfmdr1 Gene and In Vitro Artemether and Lumefantrine Sensitivity in Thai Isolates of Plasmodium falciparum
- (2010) Mathirut Mungthin et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Selection of Known Plasmodium falciparum Resistance-Mediating Polymorphisms by Artemether-Lumefantrine and Amodiaquine- Sulfadoxine-Pyrimethamine but Not Dihydroartemisinin- Piperaquine in Burkina Faso
- (2010) A. F. Some et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso
- (2010) Halidou Tinto et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Plasmodium falciparumMultidrug Resistance Protein 1 and Artemisinin‐Based Combination Therapy in Africa
- (2009) Sabina Dahlström et al. JOURNAL OF INFECTIOUS DISEASES
- In Vivo Selection ofPlasmodium falciparumParasites Carrying the Chloroquine-SusceptiblepfcrtK76 Allele after Treatment with Artemether-Lumefantrine in Africa
- (2009) Christin Sisowath et al. JOURNAL OF INFECTIOUS DISEASES
- Artemisinin-Resistant Malaria in Asia
- (2009) Harald Noedl et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started